| Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines G Ghilardi, L Paruzzo, J Svoboda, EA Chong, AA Shestov, L Chen, ... Blood Advances 8 (3), 653-666, 2024 | 12 | 2024 |
| Preconditioning frailty phenotype influences survival and relapse for older allogeneic transplantation recipients AD Sung, T Koll, SH Gier, A Racioppi, G White, M Lew, M Free, P Agarwal, ... Transplantation and Cellular Therapy 30 (4), 415. e1-415. e16, 2024 | 8 | 2024 |
| CAR T-cell immunotherapy in minority patients with lymphoma G Ghilardi, S Williamson, R Pajarillo, L Paruzzo, L Chen, C Grady, ... NEJM evidence 3 (4), EVIDoa2300213, 2024 | 8 | 2024 |
| Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel G Ghilardi, L Paruzzo, V Patel, J Svoboda, ER Chong, E Fardella, ... Journal of Hematology & Oncology 17 (1), 19, 2024 | 2 | 2024 |
| Post-transplant frailty phenotype predicts survival AD Hadjis, GW White, SI Gill, N Hossain, NV Frey, EO Hexner, XJ Bruno, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | 2 | 2024 |
| Frail and pre-frail older adults with acute myeloid leukemia have inferior survival due to higher rates of disease-related deaths AD Hadjis, GW White, C Catania, NV Frey, S Gill, EO Hexner, XJ Bruno, ... Blood 142, 376, 2023 | 2 | 2023 |
| Access and Outcomes of Minority Health Populations Receiving Commercial Anti-CD19 CART Therapy for Non-Hodgkin Lymphoma G Ghilardi, S Williamson, R Pajarillo, L Paruzzo, L Chen, C Grady, ... Blood 142, 2416, 2023 | 1 | 2023 |
| Defining the Cellular and Molecular Features of CD4 T Cell Reconstitution Post Allo-HCT KG Kumashie, M Gallagher, L Babiker, N De Luna, A Kriews, G White, ... Blood 144, 7368, 2024 | | 2024 |
| Association of Fried’s frailty phenotype, but not the clinical frailty scale, with overall survival in older adults with acute myeloid leukemia. J Schmoyer, AD Hadjis, GW White, C Lai, SR McCurdy Journal of Clinical Oncology 42 (16_suppl), e23222-e23222, 2024 | | 2024 |
| Streamlined measurement of chimeric antigen receptor T-cell concentration, size, viability and two-color phenotyping during manufacturing R Pajarillo, L Paruzzo, A Carturan, O Ugwuanyi, G White, P Guruprasad, ... Cytotherapy 26 (5), 506-511, 2024 | | 2024 |
| Bendamustine Is Less Toxic Than Fludarabine-Cyclophosphamide-Based Lymphodepletion before CD28-Costimulated CART19 through Reduced Inflammatory Cytokines G Ghilardi, L Paruzzo, J Svoboda, EA Chong, A Shestov, L Chen, ... Blood 142, 4483, 2023 | | 2023 |
